Bases Clínicas para un Nuevo Modelo de Atención a la Psicosis

Erreferentzia bibliografikoak

• American Psychiatric Association. (2004). Practice guideline for the treatment of patients with schizophrenia (2nd edition). Washington, DC: Author.
• American Psychiatric Association. (2010). Attenuated Psychotic Symptoms Syndrome. http://www. dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=412
• Bendall, S., Jackson, H. J., Hulbert, C. A. y McGorry, P. D. (2008). Childhood trauma and psychotic disorders: A systematic, critical review of the evidence. Schizophrenia Bulletin, 34, 568-579.
• Bentall, R. P. (2005). Madness explained. London: Penguin.
• Birchwood, M. (2000). The critical period for early psychosis. En M. Birchwood, D. Fowler y C. Jackson (Eds.), Early intervention in psychosis: A guide to concepts, evidence and interventions (pp. 28-63). Chichester, UK: Wiley.
• Birchwood, M. y Spencer, E. (2003). Psychotherapies for schizophrenia: A review. En M. Maj y N. Sartorius (Eds.), Schizophrenia (WPA Series: Evidence and experience in psychiatry, Vol. 2) (pp. 153-220). Chichester, UK: Wiley.
• Birchwood, M. y Tarrier, N. (1992). Innovations in the psychological management of schizophrenia: Assessment, treatment and services. Chichester, UK: Wiley.
• Birchwood, M., Todd, P. y Jackson, C. (1998). Early intervention in psychosis: The critical period hypothesis. British Journal of Psychiatry, 172 (Suppl. 33), 53-59.
• Birchwood, M. y Trower, P. (2006). The future of cognitive-behavioural therapy for psychosis: Not a quasi-neuroleptic. British Journal of Psychiatry, 188, 107-108.
• Broome, M. R., Woolley, J. B., Johns, L. C., Valmaggia, L. R., Tabraham, P., Gafoor, R., et al. (2005). Outreach and support in South London (OASIS): Implementation of a clinical service for prodromal psychosis and the at risk mental state. European Psychiatry, 20, 372-378.
• Brown, G. W., Birley, J. L. y Wing, J. F. (1972). Influence of family life on the course of schizophrenic disorders: A replication. British Journal of Psychiatry, 121, 241-258.
• Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., et al. (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin, 36, 71-93.
• Canadian Psychiatric Association. (2005). Clinical practice guidelines: Treatment of schizophrenia. Canadian Journal of Psychiatry, 50 (Suppl. 1), 13.
• Carpenter, W. T. (2009). Anticipating DSM-V: Should psychosis risk became a diagnostic class? Schizophrenia Bulletin, 35, 841-843.
• Cornblatt, B., Lencz, T., Smith, S. y Auther, A. (2004). Treatment of schizophrenia prodrome. En W. S. Stone, S. V. Faraone y M. T. Tsuang (Eds.), Early clinical intervention and prevention in schizophrenia (pp. 303-323). Totowa, NJ: Humana Press.
• Chadwick, P., Birchwood, M. y Trower, P. (1996). Cognitive therapy for delusions, voices and paranoia. Chichester, UK: Wiley.
• Chadwick, P., Birchwood, M. y Trower, P. (1997). Cognitive behaviour therapy for delusions, voices and paranoia. Chichester, UK: Wiley.
• Chadwick, P. y Lowe, F. (1990). The measurement and modification of delusional beliefs. Journal of Consulting and Clinical Psychology, 58, 225-232.
• Chadwick, P. D. J. y Lowe, C. F. (1994). A cognitive approach to measuring and modifying delusions. Behaviour Research and Therapy, 32, 355-367.
• De Loore, E., Gunther, N., Drukker, M., Feron, F., Sabbe, B., Deboutte, D., et al. (2008). Auditory hallucinations in adolescence: A longitudinal general population study. Schizophrenia Research, 102, 229-230.
• Dixon, L. B., Dickerson, F., Bellack, A. S., Bennett, M., Dickinson, D., Goldberg, R. W., et al. (2010). The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophrenia Bulletin, 36, 48-70.
• Dixon, L. B. y Lehman, A. F. (1995). Family interventions for schizophrenia. Schizophrenia Bulletin, 21, 631-644.
• Fisher, M., Holland, C., Merzenich, M. M. y Vivogradov, S. (2009). Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. American Journal of Psychiatry, 166, 805-811.
• Fonseca, E., Muñiz, J., Lemos, S., Paino, M. y Villazón, U. (2010). Esquizo-Q: Cuestionario Oviedo para la evaluación de la esquizotipia. Madrid: TEA Ediciones.
• Fonseca Pedrero, E., Muñiz, J., Lemos Giráldez, S., García Cueto, E., Campillo Alvarez, A. y Villazón García, U. (2007). La multidimensionalidad de la esquizotipia a revisión [Multidimensionality of schizotypy under review]. Papeles del Psicólogo, 28, 117-126.
• Fowler, D., Garety, P. y Kuipers, E. (1995). Cognitive behaviour therapy for psychosis: Theory and practice. Chichester, UK: Wiley.
• Fowler, D., Hodgekins, J., Painter, M., Reilly, T., Crane, C., Macmillan, I., et al. (2009). Cognitive behaviour therapy for improving social recovery in psycosis: A report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine, 39, 1627-1636.
• Freeman, D., Bentall, R. y Garety, P. (Eds.). (2008). Persecutory delusions: Assessment, theory, and treatment. Oxford: Oxford University Press.
• French, P. y Morrison, A. P. (2004). Early detection and cognitive therapy for people at high risk of developing psychosis: A treatment approach. Chichester, UK: Wiley.
• Garety, P., Kuipers, L., Fowler, D., Chamberlain, F. y Dunn, G. (1994). Cognitive behavioural therapy for drug-resistant psychosis. British Journal of Medical Psychology, 67, 259-271.
• Garety, P. A. y Freeman, D. (1999). Cognitive approaches to delusions: A critical review of theories and evidence. British Journal of Clinical Psychology, 38, 113-154.
• Garety, P. A., Kuipers, E., Fowler, D., Freeman, D. y Bebbington, P. E. (2001). A cognitive model of the positive symptoms of psychosis. Psychological Medicine, 31, 189-195.
• Geddes, J. R., Burgess, S., Hawton, K., Jamison, K. y Goodwin, G. M. (2004). Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. American Journal of Psychiatry, 161, 217- 222.
• Ginsberg, L. D. (2006). A retrospective analysis of changing from alternative agents to carbazepine extended release capsules in bipolar disorder. Annals of Clinical Psychiatry, 18 (Suppl 1), 31- 34.
• Girón, M., Fernandez-Yañez, A., Maña-Alvarenga, S., Molina-Habas, A., Nolasco, A. y GómezBeneyto, M. (2010). Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: A 2-year randomized controlled study. Psychological Medicine, 40, 73-84.
• Gleeson, J. F. M., Cotton, S. M., Alvarez-Jiménez, M., Wade, D., Gee, D., Crisp, K., et al. (2009). A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. Journal of Clinical Psychiatry, 24, e1-e10.
• Grupo de trabajo de la Guía de Práctica Clínica sobre la Esquizofrenia y el Trastorno Psicótico Incipiente. (2009). Guía de Práctica Clínica sobre la Esquizofrenia y el Trastorno Psicótico Incipiente. Madrid: Ministerio de Sanidad y Consumo.
• Gumley, A. y Schwannauer, M. (2006). Staying well after psychosis: A cognitive interpersonal approach to recovery and relapse prevention. Chichester, UK: Wiley.
• Haddock, G. y Slade, P. D. (Eds.). (1996). Cognitive-behavioural interventions with psychotic disorders. London: Routledge.
• Hanssen, M., Bak, M., Bijl, R., Vollebergh, W. y van Os, J. (2005). The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology, 44, 181-191.
• Hanssen, M. S. S., Bijl, R. V., Vollebergh, W. y van Os, J. (2003). Self-reported psychotic experiences in the general population: A valid screening tool for DSM-III-R psychotic disorder? Acta Psychiatrica Scandinavica, 107, 369-377.
• Henry, L. P., Edwards, J., Jackson, H. J., Hulbert, C. A. y McGorry, P. D. (2002). Cognitively oriented psychotherapy for first-episode psychosis (COPE): A practitioner’s manual. Melbourne: EPPIC.
• Howes, O. D. y Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III-the final common pathway. Schizophrenia Bulletin, 35, 549-562.
• Jackcson, C., Trower, P., Reid, I., Smith, J., Hall, M., Townend, M., et al. (2009). Improving psychological adjustment following a first episode of pcyhsosis: A randomised controlled trial of cognitive therapy to reduce postpsychotic trauma symptoms. Behaviour Research and Therapy, 47, 454-462.
• Jackson, H., McGorry, P., Edwards, J., Hulbert, C., Henry, L., Francey, S., et al. (1998). Cognitivelyoriented psychotherapy for early psychosis (COPE): Preliminary results. British Journal of Psychiatry, 172 (Suppl.33), 93-100.
• Jackson, H., McGorry, P., Henry, L., Edwards, J., Hulbert, C., Harrigan, S., et al. (2001). Cognitively oriented psychotherapy for early psychosis (COPE): A 1-year follow-up. British Journal of Clinical Psychology, 40, 57-70.
• Jackson, H. J., McGorry, P., Edwards, J., Hulbert, C., Henry, L., Harrigan, S., et al. (2005). A con- trolled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four year follow-up readmission data. Psychological Medicine, 35, 1-12.
• Jackson, H. J. y McGorry, P. D. (Eds.). (2009). The recognition and management of early psychosis: A preventive approach (2nd ed.). Cambridge, UK: Cambridge University Pess.
• Johannessen, J. O. y McGorry, P. (2010). DSM-5 and the ‘Psychosis Risk Syndrome’: The need for a broader perspective. Psychosis, 2, 93-96.
• Johns, L. C. y van Os, J. (2001). The continuity of psychotic experiences in the general population. Clinical Psychology Review, 21, 1125-1141.
• Jones, P. B., Barnes, T. R., Davies, L. D., Dunn, G., Lloyd, H., Hayhurst, K. P., et al. (2006). Randomized controlled trial of the effect on qual- ity of life of second- vs first-generation antipsychotic drugs in schizophrenia. Archives of General Psychiatry, 63, 1079-1087.
• Kaymaz, N. y van Os, J. (2010). DSM-5 and the ‘Psychosis Risk Syndrome’: Babylonic confusion. Psychosis, 2, 100-103.
• Keefe, R. S. E., Bilder, R. M., Davis, S. M., Harvey, P. D., Palmer, B. W., Gold, J. M., et al. (2007). Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Archives of General Psychiatry, 64, 633-647.
• Kern, R. S., Glynn, S. M., Horan, W. P. y Marder, S. R. (2009). Psychosocial treatments to promote functional recovery in schizophrenia. Schizophrenia Bulletin, 35, 347-361.
• Khan, A., Khan, S. R., Leventhal, R. M. y Brown, W. A. (2001). Symptom reductions and suicide risks among patients treated with placebo in antipsychotic clinical trials: An analysis of the Food and Drug Administration database. American Journal of Psychiatry, 158, 1449-1454.
• Kingdon, D., Hansen, L. y Turkington, D. (2010). DSM-5 and the ‘Psychosis Risk Syndrome’: Would it be useful and where would it fit? Psychosis, 2, 103-106.
• Kingdon, D. G. y Turkington, D. (1994). Cognitivebehavioral therapy of schizophrenia. Hove, UK: Erlbaum.
• Leff, J. (1987). Changing the family environment of schizophrenic patients. En J. S. Strauss, W. Böker y H. D. Brenner (Eds.), Psychosocial treatment of schizophrenia (pp. 87-93). Toronto: Hans Huber.
• Lemos-Giráldez, S., Vallina-Fernández, O., Fernández-Iglesias, P., Vallejo-Seco, G., FonsecaPedrero, E., Paíno-Piñeiro, M., et al. (2009). Symptomatic and functional outcome in youth at ultra-high risk for psychosis: A longitudinal study. Schizophrenia Research, 115, 121-129.
• Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209-1223.
• Maher, B. A. (1988). Anomalous experience and delusional thinking: The logic of explanations. En T. F. Oltmanns y B. A. Maher (Eds.), Delusional beliefs (pp. 15-33). New York: Wiley.
• McFarlane, W. (1994). Multiple family groups and psychoeducation in the treatment of schizophrenic. New Directions in Mental Health Services, 62, 13-22.
• McGlashan, T. H., Addington, J., Cannon, T., Heinimaa, M., McGorry, P., O’Brien, M., et al. (2007). Recruitment and treatment practices for help-seeking “prodromal” patients. Schizophrenia Bulletin, 33, 715-726.
• McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T. J., Woods, S. W., et al. (2003). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. Study rational and design. Schizophrenia Research, 61, 7-18.
• McGorry, P. (1998). Preventive strategies in early psychosis: Verging on reality. British Journal of Psychiatry, 172 (Suppl. 33), 1-2.
• McGorry, P. D. (2000). Psychotherapy and recovery in early psychosis: A core clinical and research challenge. En B. Martingale, A. Bateman, M. Crowe y F. Margison (Eds.), Psychosis: Psychological approaches and their effectiveness (pp. 266-292). London: Gaskell/Royal College of Psychiatrists.
• McGorry , P. D. (in press). Risk syndromes, clinical staging and DSM-V: New diagnostic infrastructure for early intervention in psychiatry. Schizophrenia Research, doi:10-1016/j.schres. 2010. 03.016.
• McGorry, P. D., Nelson, B., Amminger, G. P., Bechdolf, A., Francey, S. M., Berger, G., et al. (2009). Intervention in individuals at ultra high risk for psychosis: A review and future directions. Journal of Clinical Psychiatry, 70, 1206-1212.
• McGorry, P. D., Yung, A., Phillips, L., Yuen, H. P., Francey, S., Cosgrave, E. M., et al. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first- episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59, 921-928.
• McKay, E., Beanlands, H., Zipursky, R., Roy, P., Leszcz, M., Landeen, J., et al. (2007). A randomised controlled trial of a group intervention to reduce engulfment and self-stigmatisation in first episode schizophrenia. Australian e-journal for the Advancement of Mental Health, 6, 1-9.
• Morrison, A. P. (2001). Cognitive therapy for audi- tory hallucinations as an alternative to antipsychotic medication: A case series. Clinical Psychology and Psychotherapy, 8, 136-147.
• Morrison, A. P., Byrne, R. y Bentall, R. P. (2010). DSM-5 and the ‘Psychosis Risk Syndrome’: Whose best interests would it serve? Psychosis, 2, 96-99.
• Morrison, A. P., French, P., Parker, S., Roberts, M., Stevens, H., Bentall, R. P., et al. (2007). Threeyear follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophrenia Bulletin, 33, 682-687.
• Morrison, A. P., French, P., Walford, L., Lewis, S. W., Kilcommons, A., Green, J., et al. (2004). Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial. British Journal of Psychiatry, 185, 291-297.
• National Institute for Health and Clinical Excellence. (2008). Schizophrenia: Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (update). National Clinical Practice Guideline Number 82.
• Nelson, B. y Yung, A. R. (2009). Psychotic-like experiences as overdetermined phenomena: When do they increase risk for psychotic disorder? Schizophrenia Research, 108, 303-304.
• Nelson, H. E. (2005). Cognitive-behavioural therapy with delusions and hallucinations (2nd ed.). Cheltenham, UK: Nelson Thornes.
• Nordentoft, M., Thorup, A., Petersen, L., Ohlenschlaeger, J., Melau, M., Christensen, T. O., et al. (2006). Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial: A randomized clinical trial of integrated treatment and standard treatment. Schizophrenia Research, 83, 29-40.
• Owens, D. G. C., Miller, P., Lawrie, S. M. y Johnstone, E. C. (2005). Pathogenesis of schizophrenia: A psychopathological perspective. British Journal of Psychiatry, 186, 386-393.
• Patterson, T. L. y Leeuwenkamp, O. R. (2008). Adjunctive psychosocial therapies for the treatment of schizophrenia. Schizophrenia Research, 100, 108-119.
• Perona Garcelán, S., Cuevas Yust, C., Vallina Fernández, O. y Lemos Giráldez, S. (2003). Terapia cognitivo-conductual de la esquizofrenia: Guía clínica. Madrid: Minerva Ediciones.
• Perris, C. y McGorry, P. D. (Eds.). (2004). Psicoterapia cognitiva para los trastornos psicóticos y de personalidad: Manual teórico-práctico. Bilbao: Desclée de Brouwer (Orig. 1998).
• Phillips, L. J., McGorry, P. D., Yuen, H. P., Ward, J., Donovan, K., Kelly, D., et al. (2007). Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophrenia Research, 96, 25-33.
• Pilling, S., Bebbington, P., Kuipers, E., Garety, P., Geddes, J., Orbach, G., et al. (2002). Psycholo- gical treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine, 32, 763-782.
• Pitschel-Walz, G., Leucht, S., Bäuml, J., Kissling, W. y Engel, R. R. (2001). The effect of family interventions on relapse and rehospitalization in schizophrenia: A meta-analysis. Schizophrenia Bulletin, 27, 73-92.
• Raine, A. (1991). The SPQ: A scale for the assessment of Schizotypal Personality Disorder based on DSM-III-R criteria. Schizophrenia Bulletin, 17, 555-564.
• Raine, A. (2006). Schizotypal personality: Neurodevelopment and psychosocial trajectories. Annual Review of Clinical Psychology, 2, 291- 326.
• Ross, C. A. (2010). DSM-5 and the ‘Psychosis Risk Syndrome’: Eight reasons to reject it.pdf. Psychosis, 2, 107-110.
• Royal Australian and New Zealand College of Psychiatrists. (2005). Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders. Australian and New Zealand Journal of Psychiatry, 39, 1-30.
• Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163, 1905-1917.
• Smith, J. y Birchwood, M. (1990). Relatives and patients as partners in the management of schizophrenia: The development of a service model. British Journal of Psychiatry, 156, 654-660.
• Swartz, M. S., Perkins, D. O., Stroup, T. S., Davis, S. M., Capuano, G., Rosenheck, R. A., et al. (2007). Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: Findings from the NIMH CATIE study. American Journal of Psychiatry, 164, 428- 436.
• Tandon, R., Nasrallah, H. A. y Keshavan, M. S. (2009). Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophrenia Research, 110, 1-23.
• Tandon, R., Nasrallah, H. A. y Keshavan, M. S. (2010). Schizophrenia, “just the facts” 5. Treatment and prevention past, present, and future. Schizophrenia Research, 122, 1-23.
• Tarrier, N. (1996). Family interventions and schizophrenia. En G. Haddock y P. D. Slade (Eds.),
• Cognitive-behavioural interventions with psychotic disorders (pp. 212-234). London: Routledge.
• Tarrier, N., Barrowclough, C., Vaughn, C., Bamrah, J. S., Porceddu, K., Watts, W., et al. (1988). The community management of schizophrenia: A controlled trial of a behavioural intervention with families to reduce relapse. British Journal of Psychiatry, 153, 532-542.
• Tarrier, N., Beckett, R., Harwood, S., Baker, A., Yusupoff, L. y Ugarteburu, I. (1993). A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry, 162, 524-532.
• Turkington, D., Kingdon, D. y Chadwick, P. (2003). Cognitive-behavioural therapy for schizophrenia: Filling the therapeutic vacuum. British Journal of Psychiatry, 183, 98-99.
• Vallina Fernández, O., Lemos Giráldez, S. y Fernández Iglesias, M. P. (2010). Gestión y práctica clínica en rehabilitación de la esquizofrenia basada en la evidencia. En A. Pastor, A. Blanco y D. Navarro (Eds.), Manual de rehabilitación del trastorno mental grave (pp. 567-600). Madrid: Síntesis.
• Vaughn, C., Doyle, M., McConaghy, N., Blascynski, A., Fox, A. y Tarrier, N. (1992). The Sidney intervention trial: A controlled trial of relatives’ counselling to reduce schizophrenic relapse. Social Psychiatry and Psychiatric Epidemiology, 27, 16- 21.
• Vaughn, C. E. y Leff, J. P. (1976). The influence of family and social factors on the course of psychiatric illness: A comparison of schizophrenic and depressed neurotic patients. British Journal of Psychiatry, 129, 125-137.
• Verdoux, H. y van Os, J. (2002). Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophrenia Research, 54, 59- 65.
• Waldheter, E. J., Penn, D. L., Perkins, D. O., Mueser, K. T., Owens, L. W. y Cook, E. (2008). The Graduated Recovery Intervention Program for first episode psychosis: Treatment development and preliminary data. Community Mental Health Journal, 44, 443-455.
• World Health Organization. (2009). WHO model list of essential medicines (16th ed.): http://www.who.int/medicines/publication/essentialmedicines/en/.
• Wright, J. H., Turkington, D., Kingdon, D. G. y Ramirez Basco, M. (2009). Cognitive-behavior therapy for severe mental illness: An illustraded guide. Washington, DC: American Psychiatric Publishing.
• Yung, A., Nelson, B., Thompson, A. D. y Wood, S. J. (in press-a). The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid? Schizophrenia Research, doi:10.1016/j.schres. 2010.03.014.
• Yung, A., Nelson, B., Thompson, A. D. y Wood, S. J. (in press-b). Should a “Risk Syndrome for Psychosis” be included in the DSMV? Schizophrenia Research, doi:10.1016/j.schres.2010.03. 017.
• Yung, A. R., Phillips, L. J., McGorry, P. D., McFarlane, C. A., Francey, S., Harrigan, S., et al. (1998). Prediction of psychosis: A step towards indicated prevention of schizophrenia. British Journal of Psychiatry, 172 (Suppl. 33), 14-20.
• Zubin, J. y Spring, B. (1977). Vulnerability: A new view of schizophrenia. Journal of Abnormal Psychology, 86, 103-126.